Get 10% Off on Every Order
DISCOUNT10
Addyi (Flibanserin) is an FDA-approved prescription medication designed to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike treatments that work immediately, Addyi is taken daily to help improve sexual desire and reduce distress related to low libido. By acting on neurotransmitters in the brain, Addyi supports a healthier balance of sexual interest and satisfaction. It should be used under the guidance of a qualified healthcare professional and according to prescribed dosing instructions.
Addyi is the brand name for flibanserin, a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by a persistent lack of sexual desire that causes significant personal distress and is not explained by another medical condition, relationship issue, medication, or psychiatric disorder.
Addyi was developed specifically to address low sexual desire in women and is often referred to as a treatment option for female sexual interest concerns. Unlike medications that are taken only when needed, Addyi is taken once daily and works gradually over time.
Sexual desire naturally varies among individuals and may change throughout life. However, HSDD involves a sustained reduction or absence of sexual desire that leads to emotional distress, frustration, or difficulties in relationships.
Women with HSDD may experience:
HSDD is a recognized medical condition and should not be confused with temporary changes in libido caused by stress, fatigue, hormonal fluctuations, pregnancy, menopause, or relationship concerns.
Addyi works differently from medications used to treat erectile dysfunction. Instead of increasing blood flow, it acts on neurotransmitters in the brain that influence sexual desire.
Flibanserin helps regulate:
Serotonin can influence sexual desire. Addyi modulates serotonin receptors to help restore balance.
Dopamine is associated with motivation, reward, and pleasure. Increased dopamine activity may support sexual interest.
Norepinephrine plays a role in attention and arousal. Addyi helps enhance neurotransmitter pathways involved in sexual desire.
Through these mechanisms, Addyi helps improve sexual desire and reduce distress associated with HSDD.
Women prescribed Addyi may experience several potential benefits, including:
Addyi is designed to increase sexual interest in women diagnosed with acquired generalized HSDD.
The medication may help reduce feelings of frustration, anxiety, or sadness related to low sexual desire.
Improved sexual desire may contribute to enhanced intimacy and relationship well-being.
Because Addyi is taken daily, it provides continuous support rather than temporary symptom management.
Addyi has been evaluated in clinical trials involving women diagnosed with HSDD and has demonstrated effectiveness for eligible patients.
Addyi is intended for:
Addyi is not approved for:
The typical dosage of Addyi is:
100 mg taken orally once daily at bedtime.
Taking Addyi at bedtime helps reduce the likelihood of certain side effects such as dizziness, sleepiness, and low blood pressure.
Patients should follow their healthcare provider's instructions and never adjust their dosage without medical guidance.
For optimal results:
Because Addyi works gradually, noticeable improvements may take several weeks.
Response to treatment varies among individuals.
Some women may begin noticing improvements within a few weeks, while others may require a longer treatment period. Healthcare providers typically evaluate effectiveness after approximately eight weeks of regular use.
If meaningful improvement is not observed after the recommended evaluation period, treatment may be reassessed.
Like all prescription medications, Addyi may cause side effects.
Common side effects include:
Most side effects are mild to moderate and may improve as the body adjusts to treatment.
Although uncommon, serious side effects may occur.
Seek immediate medical attention if you experience:
Always discuss potential risks with your healthcare provider before starting treatment.
Before using Addyi, inform your healthcare provider about:
Proper medical evaluation helps determine whether Addyi is appropriate for your specific circumstances.
Certain medications may interact with Addyi and affect its safety or effectiveness.
Potential interactions may occur with:
Always provide a complete list of medications and supplements to your healthcare provider.
Patients should carefully follow healthcare guidance regarding alcohol consumption while using Addyi.
Combining alcohol with Addyi may increase the risk of dizziness, low blood pressure, or fainting. Follow current prescribing information and professional medical advice.
Store Addyi:
Do not use expired medication.
Addyi remains one of the most recognized prescription treatments specifically developed for women experiencing acquired generalized HSDD.
Key reasons patients may consider Addyi include:
Addyi is a prescription medication that should only be used under the supervision of a licensed healthcare professional. Individual results vary, and treatment suitability depends on a comprehensive medical assessment.
Addyi is prescribed for acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women who experience persistent low sexual desire that causes personal distress.
Addyi is not an immediate treatment. Some women may notice improvement within several weeks, while full benefits may take up to eight weeks or longer.
No. Addyi is designed to be taken once daily at bedtime and should not be used only before sexual activity.
Common side effects include dizziness, sleepiness, fatigue, nausea, dry mouth, and low blood pressure.
Yes. Addyi is a prescription-only medication and should be used under the supervision of a qualified healthcare provider after proper evaluation.
Best Shipping Service
Always Guaranteed
Checkout System
0 Review(s)